AmyElizabethGeddisMD
Pediatric Hematology & Oncology • Seattle, WAAssociate Professor, Pediatrics, UCSD School of Medicine
Are you Dr. Geddis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2106Fax+1 206-987-3946
Summary
- Dr. Amy Geddis, MD is a pediatric hematologist/oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Alaska, and Montana. She is affiliated with Seattle Children's Hospital and is an Associate Professor at UCSD School of Medicine.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1997 - 2000
UPMC Medical EducationResidency, Pediatrics, 1994 - 1997
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
CA State Medical License 2002 - Present
AK State Medical License 2021 - 2026
MT State Medical License 2021 - 2025
WA State Medical License 1997 - 2025
PA State Medical License 1995 - 1998- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma Start of enrollment: 2006 Jul 20
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma Start of enrollment: 2009 Jun 05
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 1 citationsTreatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.Kristin A Shimano, Ghadir Sasa, Larisa Broglie, Nicholas J Gloude, Kasiani Myers
Pediatric Blood & Cancer. 2024-08-01 - 2 citationsTreatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.Kristin A Shimano, Jennifer A Rothman, Steven W Allen, Paul Castillo, Jill L O de Jong
Pediatric Blood & Cancer. 2024-08-01 - 12 citationsResponse to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response.Elissa R Engel, Adrienne Hammill, Denise Adams, Roderic J Phillips, Michael Jeng
Pediatric Blood & Cancer. 2023-04-01
Grant Support
- Molecular And Cellular Biology Of ThrombopoietinNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Molecular And Cellular Biology Of ThrombopoietinNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Molecular And Cellular Biology Of ThrombopoietinNational Institute Of Diabetes And Digestive And Kidney Diseases2008
- Anti-Idiotype Monoclonal Antibody As A Tumor Vaccine For NeuroblastomaNational Center For Research Resources2005
- The Role Of Pl3k In Thrombopoietin SignalingNational Heart, Lung, And Blood Institute2002–2005
- Anti-Idiotype MAB As A Tumor Vaccine For NeuroblastomaNational Center For Research Resources2004
- The Role Of Pl3k In Thrombopoietin SignalingNational Heart, Lung, And Blood Institute2001
